Diagnostic Specialty Enzyme Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the diagnostic specialty enzyme market looks promising with opportunities in pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The global diagnostic specialty enzyme market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increase in the use of enzymes in biotech & diagnostic applications; a surge in investment; rise in prevalence of chronic, infectious, and lifestyle diseases; and early and instant diagnosis of life threatening diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global diagnostic specialty enzyme market report, please download the report brochure.
In this market, polymerases & nucleases is the largest product of diagnostic specialty enzyme, whereas pharmaceuticals is the largest application. Growth in various segments of the diagnostic specialty enzyme market are given below:
The study includes trends and forecast for the global diagnostic specialty enzyme market by product, source, application, form, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ProteaseCarbohydrasesPolymerases and NucleasesLipase
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
MicroorganismsPlantsAnimals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
PharmaceuticalsResearch & biotechnologyDiagnosticsBiocatalysts
By Form [Value ($ Million) shipment analysis for 2014 – 2025]:
LiquidDry
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the diagnostic specialty enzyme companies profiled in this report include F. Hoffmann-La Roche, Novozymes, Codexis, Amano Enzyme, Advanced Enzyme Technologies, Affymetrix, DuPont, BASF, Life technologies, and Sanofi
Lucintel forecasts that polymerases and nucleases will remain the largest product segment over the forecast period due to rise in the usage of polymerase and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification.
Within this market, pharmaceuticals will remain the largest application segment over the forecast period due to increasing incorporation of enzymes in therapies for diseases, such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management.
North America will remain the largest region over the forecast period due to increase in adoption of new biotechnology technologies, such as next generation sequencing, and significant research spending in overall national budgets.
Features of the Global Diagnostic Specialty Enzyme Market
Market Size Estimates: Global diagnostic specialty enzyme market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global diagnostic specialty enzyme market size by various segments, such as product, source, application, and form in terms of value.Regional Analysis: Global diagnostic specialty enzyme market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, source, application, form, and region for the global diagnostic specialty enzyme market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global diagnostic specialty enzyme market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global diagnostic specialty enzyme market by product (protease, carbohydrases, polymerases and nucleases, and lipase), source (microorganisms, plants, and animals), application (pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts), form (liquid and dry), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global diagnostic specialty enzyme market?
Q.5 What are the business risks and threats to the global diagnostic specialty enzyme market?
Q.6 What are the emerging trends in this diagnostic specialty enzyme market and the reasons behind them?
Q.7 What are some changing demands of customers in this diagnostic specialty enzyme market?
Q.8 What are the new developments in this diagnostic specialty enzyme market? Which companies are leading these developments?
Q.9 Who are the major players in this diagnostic specialty enzyme market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this diagnostic specialty enzyme market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global diagnostic specialty enzyme market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Protease, Carbohydrases, Polymerases and Nucleases, and Lipase), Source (Microorganisms, Plants, and Animals), Application (Pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), and Form (Liquid and Dry),
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the diagnostic specialty enzyme market looks promising with opportunities in pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The global diagnostic specialty enzyme market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increase in the use of enzymes in biotech & diagnostic applications; a surge in investment; rise in prevalence of chronic, infectious, and lifestyle diseases; and early and instant diagnosis of life threatening diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global diagnostic specialty enzyme market report, please download the report brochure.
In this market, polymerases & nucleases is the largest product of diagnostic specialty enzyme, whereas pharmaceuticals is the largest application. Growth in various segments of the diagnostic specialty enzyme market are given below:
The study includes trends and forecast for the global diagnostic specialty enzyme market by product, source, application, form, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
ProteaseCarbohydrasesPolymerases and NucleasesLipase
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
MicroorganismsPlantsAnimals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
PharmaceuticalsResearch & biotechnologyDiagnosticsBiocatalysts
By Form [Value ($ Million) shipment analysis for 2014 – 2025]:
LiquidDry
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the diagnostic specialty enzyme companies profiled in this report include F. Hoffmann-La Roche, Novozymes, Codexis, Amano Enzyme, Advanced Enzyme Technologies, Affymetrix, DuPont, BASF, Life technologies, and Sanofi
Lucintel forecasts that polymerases and nucleases will remain the largest product segment over the forecast period due to rise in the usage of polymerase and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification.
Within this market, pharmaceuticals will remain the largest application segment over the forecast period due to increasing incorporation of enzymes in therapies for diseases, such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management.
North America will remain the largest region over the forecast period due to increase in adoption of new biotechnology technologies, such as next generation sequencing, and significant research spending in overall national budgets.
Features of the Global Diagnostic Specialty Enzyme Market
Market Size Estimates: Global diagnostic specialty enzyme market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global diagnostic specialty enzyme market size by various segments, such as product, source, application, and form in terms of value.Regional Analysis: Global diagnostic specialty enzyme market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, source, application, form, and region for the global diagnostic specialty enzyme market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global diagnostic specialty enzyme market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global diagnostic specialty enzyme market by product (protease, carbohydrases, polymerases and nucleases, and lipase), source (microorganisms, plants, and animals), application (pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts), form (liquid and dry), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global diagnostic specialty enzyme market?
Q.5 What are the business risks and threats to the global diagnostic specialty enzyme market?
Q.6 What are the emerging trends in this diagnostic specialty enzyme market and the reasons behind them?
Q.7 What are some changing demands of customers in this diagnostic specialty enzyme market?
Q.8 What are the new developments in this diagnostic specialty enzyme market? Which companies are leading these developments?
Q.9 Who are the major players in this diagnostic specialty enzyme market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this diagnostic specialty enzyme market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global diagnostic specialty enzyme market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Protease, Carbohydrases, Polymerases and Nucleases, and Lipase), Source (Microorganisms, Plants, and Animals), Application (Pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), and Form (Liquid and Dry),
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Diagnostic Specialty Enzyme Market Trends and Forecast
3.3: Global Diagnostic Specialty Enzyme Market by Product
3.3.1: Protease
3.3.2: Carbohydrases
3.3.3: Polymerases and Nucleases
3.3.4: Lipase
3.4: Global Diagnostic Specialty Enzyme Market by Source
3.4.1: Microorganisms
3.4.2: Plants
3.4.3: Animals
3.5: Global Diagnostic Specialty Enzyme Market by Application
3.5.1: Pharmaceuticals
3.5.2: Research & biotechnology
3.5.3: Diagnostics
3.5.4: Biocatalysts
3.6: Global Diagnostic Specialty Enzyme Market by Form
3.5.1: Liquid
3.5.2: Dry
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Diagnostic Specialty Enzyme Market by Region
4.2: North American Diagnostic Specialty Enzyme Market
4.2.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.2.2: Market by Source: Microorganisms, Plants, and Animals
4.2.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.2.4: Market by Form: Liquid and Dry
4.2.5: The United States Diagnostic Specialty Enzyme Market
4.2.6: The Canadian Diagnostic Specialty Enzyme Market
4.2.7: The Mexican Diagnostic Specialty Enzyme Market
4.3: European Diagnostic Specialty Enzyme Market
4.3.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.3.2: Market by Source: Microorganisms, Plants, and Animals
4.3.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.3.4: Market by Form: Liquid and Dry
4.3.5: The United Kingdom Diagnostic Specialty Enzyme Market
4.3.6: The Spanish Diagnostic Specialty Enzyme Market
4.3.7: The German Diagnostic Specialty Enzyme Market
4.3.8: The French Diagnostic Specialty Enzyme Market
4.4: APAC Diagnostic Specialty Enzyme Market
4.4.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.4.2: Market by Source: Microorganisms, Plants, and Animals
4.4.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.4.4: Market by Form: Liquid and Dry
4.4.5: The Chinese Diagnostic Specialty Enzyme Market
4.4.6: The Indian Diagnostic Specialty Enzyme Market
4.4.7: The Japanese Diagnostic Specialty Enzyme Market
4.5: ROW Diagnostic Specialty Enzyme Market
4.5.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.5.2: Market by Source: Microorganisms, Plants, and Animals
4.5.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.5.4: Market by Form: Liquid and Dry
4.5.5: Brazilian Diagnostic Specialty Enzyme Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Product
7.1.2: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Source
7.1.3: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Application
7.1.4: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Form
7.1.5: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Region
7.2: Emerging Trends in the Global Diagnostic Specialty Enzyme Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Diagnostic Specialty Enzyme Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Specialty Enzyme Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Diagnostic Specialty Enzyme Market Trends and Forecast
3.3: Global Diagnostic Specialty Enzyme Market by Product
3.3.1: Protease
3.3.2: Carbohydrases
3.3.3: Polymerases and Nucleases
3.3.4: Lipase
3.4: Global Diagnostic Specialty Enzyme Market by Source
3.4.1: Microorganisms
3.4.2: Plants
3.4.3: Animals
3.5: Global Diagnostic Specialty Enzyme Market by Application
3.5.1: Pharmaceuticals
3.5.2: Research & biotechnology
3.5.3: Diagnostics
3.5.4: Biocatalysts
3.6: Global Diagnostic Specialty Enzyme Market by Form
3.5.1: Liquid
3.5.2: Dry
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Diagnostic Specialty Enzyme Market by Region
4.2: North American Diagnostic Specialty Enzyme Market
4.2.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.2.2: Market by Source: Microorganisms, Plants, and Animals
4.2.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.2.4: Market by Form: Liquid and Dry
4.2.5: The United States Diagnostic Specialty Enzyme Market
4.2.6: The Canadian Diagnostic Specialty Enzyme Market
4.2.7: The Mexican Diagnostic Specialty Enzyme Market
4.3: European Diagnostic Specialty Enzyme Market
4.3.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.3.2: Market by Source: Microorganisms, Plants, and Animals
4.3.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.3.4: Market by Form: Liquid and Dry
4.3.5: The United Kingdom Diagnostic Specialty Enzyme Market
4.3.6: The Spanish Diagnostic Specialty Enzyme Market
4.3.7: The German Diagnostic Specialty Enzyme Market
4.3.8: The French Diagnostic Specialty Enzyme Market
4.4: APAC Diagnostic Specialty Enzyme Market
4.4.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.4.2: Market by Source: Microorganisms, Plants, and Animals
4.4.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.4.4: Market by Form: Liquid and Dry
4.4.5: The Chinese Diagnostic Specialty Enzyme Market
4.4.6: The Indian Diagnostic Specialty Enzyme Market
4.4.7: The Japanese Diagnostic Specialty Enzyme Market
4.5: ROW Diagnostic Specialty Enzyme Market
4.5.1: Market by Product: Protease, Carbohydrases, Polymerases and Nucleases, and Lipase
4.5.2: Market by Source: Microorganisms, Plants, and Animals
4.5.3: Market by Application: Pharmaceuticals, Research & biotechnology, Diagnostics, and Biocatalysts
4.5.4: Market by Form: Liquid and Dry
4.5.5: Brazilian Diagnostic Specialty Enzyme Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Product
7.1.2: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Source
7.1.3: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Application
7.1.4: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Form
7.1.5: Growth Opportunities for the Global Diagnostic Specialty Enzyme Market by Region
7.2: Emerging Trends in the Global Diagnostic Specialty Enzyme Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Diagnostic Specialty Enzyme Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Specialty Enzyme Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche
